Synopsis
Synopsis
0
EU WC
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Eqvalan
2. Ivermectin
3. Ivomec
4. Mectizan
5. Mk 933
6. Mk-933
7. Mk933
8. Stromectol
1. Ivermectin
2. Dihydroavermectin B1a
3. 70288-86-7
4. 22,23-dihydroavermectin B1a
5. 70161-11-4
6. Ivermectin Component B1a
7. 71827-03-7
8. Avermectin H2b1a
9. 5-o-demethyl-22,23-dihydroavermectin A1a
10. Chebi:63941
11. 91y2202ouw
12. (2ae,4e,5's,6s,6'r,7s,8e,11r,13r,15s,17ar,20r,20ar,20bs)-6'-[(2s)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2h,7h-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-o-(2,6-dideoxy-3-o-methyl-alpha-l-arabino-hexopyranosyl)-3-o-methyl-alpha-l-arabino-hexopyranoside
13. Mk-933
14. (1r,4s,5's,6r,6'r,8r,10e,12s,13s,14e,16e,20r,21r,24s)-6'-[(2s)-butan-2-yl]-21,24-dihydroxy-12-[(2r,4s,5s,6s)-5-[(2s,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one
15. Ivermectin B1a-d2
16. C48h74o14
17. Unii-91y2202ouw
18. 22,23-dihydroavermectin B(1)a
19. Ncgc00163233-01
20. Ivermectin (ivm)
21. Ivm
22. Einecs 276-046-2
23. Dihydro Avermectin Bla
24. Brn 4643153
25. 22,23-dihydro-5-o-demethylavermectin A1a
26. H2b1a
27. Prestwick3_000156
28. Dsstox_cid_3181
29. Ivermectin (mk-0933)
30. Dsstox_rid_76909
31. Dsstox_gsid_23181
32. Bspbio_000292
33. Schembl312795
34. Bpbio1_000322
35. Chembl263291
36. Dtxsid8023181
37. Chebi:94551
38. Hms2089m09
39. Hms2095o14
40. Hms3712o14
41. Wca82703
42. Tox21_112034
43. Bdbm50409816
44. Mfcd30496678
45. S1351
46. Akos027470116
47. Ivermectin Component B1a [mi]
48. Zinc238808778
49. Zinc252286706
50. Ac-6014
51. Ccg-220156
52. Ncgc00186639-01
53. Ncgc00186639-03
54. As-14167
55. Bi166167
56. Cas-71827-03-7
57. Hy-126937
58. Ab00513813
59. Cs-0108408
60. 22,23-dihydroavermectin B1a; Ivermectin
61. Ab00513813-02
62. Ab00513813-03
63. Ab00513813_04
64. Avermectin A1a, 22,23-dihydro-5-o-demethyl-
65. 288i867
66. Ivermectin, Antibiotic For Culture Media Use Only
67. Q-201262
68. Brd-k24652731-001-02-7
69. Brd-k85554912-001-08-9
70. Q27132923
71. Ivermectin, British Pharmacopoeia (bp) Reference Standard
72. Ivermectin, European Pharmacopoeia (ep) Reference Standard
73. Ivermectin, United States Pharmacopeia (usp) Reference Standard
74. Ivermectin, Pharmaceutical Secondary Standard; Certified Reference Material
75. (2ae,4e,5's,6s,6'r,7s,8e,11r,13r,15s,17ar,20r,20ar,20bs)-6'-[(2s)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17
76. Clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-o-(2,6-dideoxy-3-o-methyl-alpha-l-arabino-hexopyranosyl)-3-o-methyl-alpha-l-arabino-hexopyranoside
Molecular Weight | 875.1 g/mol |
---|---|
Molecular Formula | C48H74O14 |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 8 |
Exact Mass | 874.50785703 g/mol |
Monoisotopic Mass | 874.50785703 g/mol |
Topological Polar Surface Area | 170 Ų |
Heavy Atom Count | 62 |
Formal Charge | 0 |
Complexity | 1680 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 20 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 3 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of rosacea
Antiparasitic Agents
Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)
Insecticides
Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)
D - Dermatologicals
D11 - Other dermatological preparations
D11A - Other dermatological preparations
D11AX - Other dermatologicals
D11AX22 - Ivermectin
P - Antiparasitic products, insecticides and repellents
P02 - Anthelmintics
P02C - Antinematodal agents
P02CF - Avermectines
P02CF01 - Ivermectin
Certificate Number : CEP 2021-382 - Rev 00
Status : Valid
Issue Date : 2024-08-02
Type : Chemical
Substance Number : 1336
Certificate Number : R0-CEP 2021-477 - Rev 00
Status : Valid
Issue Date : 2022-04-22
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2008-104 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2020-06-08
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 1998-138 - Rev 05
Status : Valid
Issue Date : 2020-02-28
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2001-146 - Rev 01
Status : Valid
Issue Date : 2008-11-27
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2004-070 - Rev 01
Status : Valid
Issue Date : 2011-08-02
Type : Chemical
Substance Number : 1336
Certificate Number : R0-CEP 2010-123 - Rev 00
Status : Expired
Issue Date : 2011-10-25
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2001-077 - Rev 01
Status : Valid
Issue Date : 2017-10-16
Type : Chemical
Substance Number : 1336
Certificate Number : R0-CEP 2006-008 - Rev 01
Status : Expired
Issue Date : 2010-06-17
Type : Chemical
Substance Number : 1336
Certificate Number : CEP 1999-176 - Rev 06
Status : Valid
Issue Date : 2025-01-10
Type : Chemical
Substance Number : 1336
Registration Number : 304MF10006
Registrant's Address : Estrada Coronel Nicolau de Mesquita Taipa, Macau S. A. R. China
Initial Date of Registration : 2022-01-11
Latest Date of Registration : 2022-01-11
Registration Number : 221MF10281
Registrant's Address : Estrada Coronel Nicolau de Mesquita Taipa, Macau S. A. R. China
Initial Date of Registration : 2009-12-18
Latest Date of Registration : 2021-10-07
Registration Number : 304MF10048
Registrant's Address : 46 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province, P. R. China 3180...
Initial Date of Registration : 2022-03-02
Latest Date of Registration : 2022-03-02
Registrant Name : Ace Biopharm Co., Ltd.
Registration Date : 2025-02-21
Registration Number : 20250221-211-J-1776
Manufacturer Name : Zhejiang Hisun Pharmaceutica...
Manufacturer Address : 56 Binhai Road, Jiaojiang District, Taizhou City, Zhejiang Province, People's Republi...
NDC Package Code : 73377-144
Start Marketing Date : 2021-08-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 73212-079
Start Marketing Date : 2023-10-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 77382-0110
Start Marketing Date : 1998-10-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 77382-0100
Start Marketing Date : 1998-10-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0619
Start Marketing Date : 1998-04-01
End Marketing Date : 2025-08-23
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 55018-221
Start Marketing Date : 2009-03-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55018-121
Start Marketing Date : 1998-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60592-316
Start Marketing Date : 2019-12-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-3195
Start Marketing Date : 2023-08-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68171-0001
Start Marketing Date : 2007-12-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 5672
Submission : 1999-11-22
Status : Inactive
Type : II
VMF Number : 5906
Submission : 2007-09-20
Status : Inactive
Type : II
VMF Number : 6221
Submission : 2018-01-16
Status : Active
Type : II
VMF Number : 5914
Submission : 2008-01-15
Status : Inactive
Type : II
VMF Number : 5476
Submission : 1993-10-22
Status : Inactive
Type : II
VMF Number : 5774
Submission : 2003-06-10
Status : Active
Type : II
VMF Number : 5720
Submission : 2001-05-11
Status : Active
Type : II
VMF Number : 5576
Submission : 1996-11-20
Status : Inactive
Type : II
VMF Number : 5797
Submission : 2004-03-24
Status : Inactive
Type : II
VMF Number : 5553
Submission : 1995-12-14
Status : Active
Type : II
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Norway
Brand Name : Scatol
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 4item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Scatol
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 12item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Sweden
Brand Name : Soolantra
Dosage Form : CREAM
Dosage Strength : 10 MG / G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Soolantra
Dosage Form : Cream
Dosage Strength : 10 mg/g
Packaging : Tube of plastic
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Brand Name : Soolantra
Dosage Form : Cream
Dosage Strength : 10mg/g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Norway
Brand Name : Ivermectin Medical Valley
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 4item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Ivermectin Medical Valley
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 10item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Ivermectin Orifarm
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 4item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Ivermectin STADA
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 4item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 1%
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Ivermectin|Pyrantel
Dosage Form : Flavoured Tablet
Dosage Strength : 68MG; 57MG
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 1
Regulatory Info :
Dosage : Flavoured Tablet
Dosage Strength : 68MG; 57MG
Brand Name : Ivermectin|Pyrantel
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 12MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 12MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Ivermectin
Dosage Form : Liquid Injection
Dosage Strength : 10MG/ML
Packaging : 1 ML, 10 ML, 30 ML, 50 ML, 100 ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 1 ML, 10 ML, 30 ML, 50 ML, 100 ML
Regulatory Info :
Dosage : Liquid Injection
Dosage Strength : 10MG/ML
Brand Name : Ivermectin
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : Egypt
Brand Name : Closaverm
Dosage Form : Injection
Dosage Strength : 5MG; 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Egypt
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 5MG; 125MG
Brand Name : Closaverm
Approval Date :
Application Number :
Registration Country : Egypt
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Sterilized Injection
Dosage Strength : 1%/100ML
Packaging : 50ml/100ml/250ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging : 50ml/100ml/250ml
Regulatory Info :
Dosage : Sterilized Injection
Dosage Strength : 1%/100ML
Brand Name :
Approval Date :
Application Number :
Registration Country : China
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Dispersible Tablet
Dosage Strength : 400MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Dispersible Tablet
Dosage Strength : 400MG; 5MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : China
Brand Name : Evermec-110 Plus
Dosage Form : Liquid Injection
Dosage Strength : 1%; 10%
Packaging : 50ML,100ML,250ML,500ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging : 50ML,100ML,250ML,500ML
Regulatory Info :
Dosage : Liquid Injection
Dosage Strength : 1%; 10%
Brand Name : Evermec-110 Plus
Approval Date :
Application Number :
Registration Country : China
Regulatory Info :
Registration Country : China
Brand Name : Evermec
Dosage Form : Oral Solution/Suspensi...
Dosage Strength : 0.5%
Packaging : 500ML,1000ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging : 500ML,1000ML
Regulatory Info :
Dosage : Oral Solution/Suspensi...
Dosage Strength : 0.5%
Brand Name : Evermec
Approval Date :
Application Number :
Registration Country : China
Regulatory Info :
Registration Country : India
Brand Name : Vibex Plus
Dosage Form : Tablet
Dosage Strength : 50MG; 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 50MG; 2MG
Brand Name : Vibex Plus
Approval Date :
Application Number :
Registration Country : India
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
50
PharmaCompass offers a list of Ivermectin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ivermectin manufacturer or Ivermectin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ivermectin manufacturer or Ivermectin supplier.
PharmaCompass also assists you with knowing the Ivermectin API Price utilized in the formulation of products. Ivermectin API Price is not always fixed or binding as the Ivermectin Price is obtained through a variety of data sources. The Ivermectin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Merck Brand of Ivermectin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Merck Brand of Ivermectin, including repackagers and relabelers. The FDA regulates Merck Brand of Ivermectin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Merck Brand of Ivermectin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Merck Brand of Ivermectin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Merck Brand of Ivermectin supplier is an individual or a company that provides Merck Brand of Ivermectin active pharmaceutical ingredient (API) or Merck Brand of Ivermectin finished formulations upon request. The Merck Brand of Ivermectin suppliers may include Merck Brand of Ivermectin API manufacturers, exporters, distributors and traders.
click here to find a list of Merck Brand of Ivermectin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Merck Brand of Ivermectin DMF (Drug Master File) is a document detailing the whole manufacturing process of Merck Brand of Ivermectin active pharmaceutical ingredient (API) in detail. Different forms of Merck Brand of Ivermectin DMFs exist exist since differing nations have different regulations, such as Merck Brand of Ivermectin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Merck Brand of Ivermectin DMF submitted to regulatory agencies in the US is known as a USDMF. Merck Brand of Ivermectin USDMF includes data on Merck Brand of Ivermectin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Merck Brand of Ivermectin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Merck Brand of Ivermectin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Merck Brand of Ivermectin Drug Master File in Japan (Merck Brand of Ivermectin JDMF) empowers Merck Brand of Ivermectin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Merck Brand of Ivermectin JDMF during the approval evaluation for pharmaceutical products. At the time of Merck Brand of Ivermectin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Merck Brand of Ivermectin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Merck Brand of Ivermectin Drug Master File in Korea (Merck Brand of Ivermectin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Merck Brand of Ivermectin. The MFDS reviews the Merck Brand of Ivermectin KDMF as part of the drug registration process and uses the information provided in the Merck Brand of Ivermectin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Merck Brand of Ivermectin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Merck Brand of Ivermectin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Merck Brand of Ivermectin suppliers with KDMF on PharmaCompass.
A Merck Brand of Ivermectin CEP of the European Pharmacopoeia monograph is often referred to as a Merck Brand of Ivermectin Certificate of Suitability (COS). The purpose of a Merck Brand of Ivermectin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Merck Brand of Ivermectin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Merck Brand of Ivermectin to their clients by showing that a Merck Brand of Ivermectin CEP has been issued for it. The manufacturer submits a Merck Brand of Ivermectin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Merck Brand of Ivermectin CEP holder for the record. Additionally, the data presented in the Merck Brand of Ivermectin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Merck Brand of Ivermectin DMF.
A Merck Brand of Ivermectin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Merck Brand of Ivermectin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Merck Brand of Ivermectin suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Merck Brand of Ivermectin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Merck Brand of Ivermectin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Merck Brand of Ivermectin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Merck Brand of Ivermectin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Merck Brand of Ivermectin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Merck Brand of Ivermectin suppliers with NDC on PharmaCompass.
Merck Brand of Ivermectin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Merck Brand of Ivermectin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Merck Brand of Ivermectin GMP manufacturer or Merck Brand of Ivermectin GMP API supplier for your needs.
A Merck Brand of Ivermectin CoA (Certificate of Analysis) is a formal document that attests to Merck Brand of Ivermectin's compliance with Merck Brand of Ivermectin specifications and serves as a tool for batch-level quality control.
Merck Brand of Ivermectin CoA mostly includes findings from lab analyses of a specific batch. For each Merck Brand of Ivermectin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Merck Brand of Ivermectin may be tested according to a variety of international standards, such as European Pharmacopoeia (Merck Brand of Ivermectin EP), Merck Brand of Ivermectin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Merck Brand of Ivermectin USP).